Abstract
The management of prolonged urinary retention following pubovaginal sling surgery typically involves transvaginal urethrolysis for anatomical urethral obstruction. Brubaker recently reported on urethral sphincter abnormalities as a cause of postoperative urinary retention following either Burch suspension or a pubovaginal sling procedure. We report a case of functional urethral obstruction and detrusor acontractility following pubovaginal sling surgery that was successfully treated by botulinum A toxin urethral sphincter injection.
Publication types
-
Case Reports
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Aged
-
Botulinum Toxins, Type A / administration & dosage
-
Botulinum Toxins, Type A / therapeutic use*
-
Female
-
Humans
-
Injections
-
Neuromuscular Agents / administration & dosage
-
Neuromuscular Agents / therapeutic use*
-
Postoperative Complications*
-
Pubic Bone / surgery*
-
Urethra / drug effects*
-
Urinary Retention / drug therapy*
-
Urinary Retention / etiology*
-
Urologic Surgical Procedures / adverse effects*
-
Vagina / surgery*
Substances
-
Neuromuscular Agents
-
Botulinum Toxins, Type A